Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Efficacy and Safety of CFTR Modulator Therapy in Adult Patients With Cystic Fibrosis

NCT05526027 is registered in ClinicalTrials.gov with Universitair Ziekenhuis Brussel as lead sponsor.

NCT NCT05526027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05526027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Efficacy and Safety of CFTR Modulator Therapy in Adult Patients With Cystic Fibrosis
Lead sponsor
Universitair Ziekenhuis Brussel
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2022
Completion date
December 31, 2024
Enrollment
85 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis